Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia

Human Genetics

Volumn 122, Issue 2, 2007, Pages 183-190

  Binder, Alexander ^a   Endler, Georg ^b   Rieger, Sandra ^b   Geishofer, Gotho ^a   Resch, Bernhard ^a   Mannhalter, Christine ^b   Zenz, Werner ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANTIBIOTIC AGENT; CATECHOLAMINE DERIVATIVE; CYTOSINE; FRESH FROZEN PLASMA; GUANINE; PROTEIN C; THYMINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUSTRIA; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMANY; GROUPS BY AGE; HETEROZYGOTE; HUMAN; HYPOTENSION; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCEMIA; MENINGOCOCCOSIS; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS; SWITZERLAND; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; EUROPE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MENINGOCOCCAL INFECTIONS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN C; SEPSIS;

EID: 34547744449     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-007-0392-5     Document Type: Article

References (52)

1. Achtmann M (1995) Global epidemiology of meningococcal disease. In: Cartwright K (ed) Meningococcal disease. Wiley, Chichester, pp 159-177
2. Aiach M, Nicaud V, Alhenc-Gelas M, Gandrille S, Arnaud E, Amiral J, Guize L, Fiessinger JN, Emmerich J (1999) Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 19:1573-1576
3. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998-2005
4. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2004) Corticosteroids for severe sepsis and septic shock: A systematic review and meta-analysis. BMJ 329:480
5. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63-78
6. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709
7. Binder A (2006) Identification of genes for a complex trait: Examples from hypertension. Curr Pharm Biotechnol 7:1-13
8. Brandtzaeg P, Sandset PM, Joo GB, Ovstebo R, Abildgaard U, Kierulf P (1989) The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 55:459-470
9. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV (2003) Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9:338-342
10. Conkling PR, Greenberg CS, Weinberg JB (1988) Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 72:128-133
11. Corrigan JJ Jr, Ray WL, May N (1968) Changes in the blood coagulation system associated with septicemia. N Engl J Med 279:851-856
12. Dahlback B, Villoutreix BO (2005) The anticoagulant protein C pathway. FEBS Lett 579:3310-3316
13. de Kleijn ED, de Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA (2003) Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 31:1839-1847
14. Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743-4746
15. Faust SN, Heyderman RS, Levin M (2001a) Coagulation in severe sepsis: A central role for thrombomodulin and activated protein C (discussion S67-S68). Crit Care Med 29:S62-S67
16. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS (2001b) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345:408-416
17. Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJ, ten Cate JW (1995) Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality. Thromb Haemost 73:15-20
18. Fisher CJ Jr, Yan SB (2000) Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 28:S49-S56
19. Foster DC, Yoshitake S, Davie EW (1985) The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 82:4673-4677
20. Fourrier F, Lestavel P, Chopin C, Marey A, Goudemand J, Rime A, Mangalaboyi J (1990) Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med 16:121-124
21. Geishofer G, Binder A, Muller M, Zohrer B, Resch B, Muller W, Faber J, Finn A, Endler G, Mannhalter C, Zenz W (2005) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr 164:486-490
22. Gregory SA, Morrissey JH, Edgington TS (1989) Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9:2752-2755
23. Guo H, Liu D, Gelbard H, Cheng T, Insalaco R, Fernandez JA, Griffin JH, Zlokovic BV (2004) Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 41:563-572
24. Haralambous E, Weiss HA, Radalowicz A, Hibberd ML, Booy R, Levin M (2003) Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol Infect 130:413-418
25. Hesselvik JF, Malm J, Dahlback B, Blomback M (1991) Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 65:126-129
26. Heyderman RS, Klein NJ, Shennan GI, Levin M (1991) Deficiency of prostacyclin production in meningococcal shock. Arch Dis Child 66:1296-1299
27. Kalil AC, Coyle SM, Um JY, LaRosa SP, Turlo MA, Calvano SE, Sundin DP, Nelson DR, Lowry SF (2004) Effects of drotrecogin alfa (activated) in human endotoxemia. Shock 21:222-229
28. Kato A, Miura O, Sumi Y, Aoki N (1988) Assignment of the human protein C gene (PROC) to chromosome region 2q14-q21 by in situ hybridization. Cytogenet Cell Genet 47:46-47
29. Leclerc F, Hazelzet J, Jude B, Hofhuis W, Hue V, Martinot A, Van der Voort E (1992) Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 cases. Intensive Care Med 18:202-205
30. Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A (1993) Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103:1536-1542
31. Macias WL, Yan SB, Williams MD, Um SL, Sandusky GE, Ballard DW, Planquois JM (2005) New insights into the protein C pathway: Potential implications for the biological activities of drotrecogin alfa (activated). Crit Care 9(Suppl 4):S38-S45
32. Mackman N (1995) Regulation of the tissue factor gene. Faseb J 9:883-889
33. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU (1987) Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 79:124-130
34. Patracchini P, Aiello V, Palazzi P, Calzolari E, Bernardi F (1989) Sublocalization of the human protein C gene on chromosome 2q13-q14. Hum Genet 81:191-192
35. Powars DR, Rogers ZR, Patch MJ, McGehee WG, Francis RBJ (1987) Purpura fulminans in meningococcemia: Association with acquired deficiencies of proteins C and S. N Engl J Med 317:571-572
36. Saez-Llorens X, McCracken GH Jr (1993) Sepsis syndrome and septic shock in pediatrics: Current concepts of terminology, pathophysiology, and management. J Pediatr 123:497-508
37. Scopes D, Berg LP, Krawczak M, Kakkar VV, Cooper DN (1995) Polymorphic variation in the human protein C (PROC) gene promoter can influence transcriptional efficiency in vitro. Blood Coagul Fibrinolysis 6:317-321
38. Shibata M, Kumar SR, Amar A, Fernandez JA, Hofman F, Griffin JH, Zlokovic BV (2001) Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 103:1799-1805
39. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW (1988) Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318:727-732
40. Spek CA, Poort SR, Bertina RM, Reitsma PH (1994) Determination of the allelic and haplotype frequencies of three polymorphisms in the promoter region of the human protein C gene. Blood Coagul Fibrinolysis 5:309-311
41. Spek CA, Greengard JS, Griffin JH, Bertina RM, Reitsma PH (1995a) Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem 270:24216-24221
42. Spek CA, Koster T, Rosendaal FR, Bertina RM, Reitsma PH (1995b) Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 15:214-218
43. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79:918-925
44. Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, Laszik Z, Kosanke S, Peer G, Esmon CT (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95:1680-1686
45. Texereau J, Pene F, Chiche JD, Rousseau C, Mira JP (2004) Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis. Crit Care Med 32:S313-S319
46. Toews WH, Bass JW (1974) Skin manifestations of meningococcal infection; an immediate indicator of prognosis. Am J Dis Child 127:173-176
47. van Teunenbroek A, Peters M, Sturk A, Borm JJ, Breederveld C (1990) Protein C activity and antigen levels in childhood. Eur J Pediatr 149:774-778
48. Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G 3rd, Bernard GR (2003) Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 31:834-840
49. Walker FJ (1981) Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 256:11128-11131
50. Walley KR, Russell JA (2007) Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit Care Med 35:12-17
51. Westendorp RG, Reitsma PH, Bertina RM (1996) Inherited prethrombotic disorders and infectious purpura. Thromb Haemost 75:899-901
52. Zenz W, Zoehrer B, Levin M, Fanconi S, Hatzis TD, Knight G, Müllner M, Faust SN (2004) Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study. Crit Care Med 32:1777-1780